AFFIVANT
LIVE

Serial Number

90850396

Owner

Affivant Sciences GmbH

Attorney

Allison Strickland Ricketts

Filing Date

Jul 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AFFIVANT Trademark

Serial Number: 90850396 • Registration: 6904414

AFFIVANT is a trademark filed by Affivant Sciences GmbH on July 27, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Affivant Sciences GmbH

Viaduktstrasse 8
Basel 4051 , CH

Entity Type: 99

Trademark Details

Filing Date

July 27, 2021

Registration Date

November 22, 2022

Published for Opposition

September 6, 2022

Goods & Services

Pharmaceutical preparations for human use, namely, for the prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations for human use comprising cell-based therapies for the treatment of oncological, neurological and immunological diseases and disorders; biologic preparations for medical and therapeutic purposes, namely, for the prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical and biological preparations for prevention and treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations comprising monoclonal antibodies and bispecific antibodies for the treatment of oncological, neurological and immunological diseases and disorders; pharmaceutical preparations comprising monoclonal antibodies and bispecific antibodies for the treatment of oncological, neurological and immunological diseases and disorders

Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceutical and biomedicine and research and design relating thereto; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 22, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 22, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 6, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 17, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Aug 3, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 29, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2022 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 4, 2021 AMPX
ASSIGNED TO LIE
Oct 4, 2021 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 24, 2021 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 4, 2021 PARI
NEW APPLICATION ENTERED
Jul 30, 2021 NWAP